We are live on ! Find out more

258 hedge funds and large institutions have $2.72B invested in Adient in 2022 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 74 increasing their positions, 80 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

592% more call options, than puts

Call options by funds: $28.6M | Put options by funds: $4.13M

0.63% less ownership

Funds ownership: 97.28%96.65% (-0.63%)

8% less repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 80

5% less funds holding

Funds holding: 271258 (-13)

20% less funds holding in top 10

Funds holding in top 10: 54 (-1)

23% less first-time investments, than exits

New positions opened: 33 | Existing positions closed: 43

28% less capital invested

Capital invested by funds: $3.75B → $2.72B (-$1.04B)

Holders
258
Holders Change
-13
Holders Change %
-4.8%
% of All Funds
4.33%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.07%
New
33
Increased
74
Reduced
80
Closed
43
Calls
$28.6M
Puts
$4.13M
Net Calls
+$24.5M
Net Calls Change
+$2.32M

ADNT Hedge Fund Activity: Q2 2022 in Review

258 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Adient (ADNT) for Q2 2022, worth a combined $2.72B — down 28% from $3.75B a quarter earlier.

Sellers outnumbered buyers: 43 funds closed out of ADNT and 33 opened new positions — a net loss of 10 holders — while 80 trimmed existing stakes and 74 added.

The largest buyer was Greenvale Capital, adding an estimated $62.2M. The largest seller was Goldman Sachs, cutting an estimated $24.1M.

  • 258 institutional investors held Adient (ADNT) as of Q2 2022, down from 271 in Q1 2022.
  • Funds reported $2.72B of Adient stock for Q2 2022, down 28% quarter-over-quarter.
  • 33 funds opened new Adient positions in Q2 2022 and 43 closed out, a net change of -10 holders.
  • The largest Adient buyer in Q2 2022 was Greenvale Capital, an estimated $62.2M added.
  • The largest Adient seller in Q2 2022 was Goldman Sachs, an estimated $24.1M sold.

Based on aggregated 13F filings for Q2 2022.